Gremubamab, previously known as this molecule, represents a promising therapeutic approach targeting BCMA in blood disorders . The therapeutic functions as an immune effector – specifically, a humanized immunoglobulin designed to stimulate the immune system to eliminate cells with BCMA . Initial … Read More